Brookfield Corporation Receives TSX Approval for Normal Course Issuer Bid to Purchase 143 Million Class A Shares

Brookfield Corporation (BN) received TSX approval to renew its share buyback program, allowing the repurchase of up to 143 million Class A shares between May 2025 and May 2026, reflecting management's belief that the current market price undervalues the company. Under the prior buyback program, Brookfield repurchased approximately 22.2 million shares at a weighted average price of US$51.20. The corporation intends to cancel all acquired shares and implement an automatic share purchase plan to facilitate ongoing repurchases.

Analysis

Brookfield Corporation (BN) has secured approval from the Toronto Stock Exchange to renew its normal course issuer bid, authorizing the repurchase of up to 143,027,158 Class A Limited Voting Shares, which constitutes 10% of the public float, over a one-year period from May 27, 2025, to May 26, 2026. This strategic move is underpinned by management's conviction that the company's shares are trading below their intrinsic value and future growth potential. Under the preceding buyback program, which commenced May 27, 2024, Brookfield repurchased 22,200,979 Class A shares as of May 15, 2025—approximately 15.5% of the total shares approved for that period—at a weighted average price of US$51.20. The corporation plans to cancel all shares acquired through the renewed bid and intends to implement an automatic share purchase plan around June 16, 2025, to ensure consistent repurchase activity, including during internal trading blackout periods. While the buyback program signals strong management confidence and aims to enhance shareholder value, the partial utilization of the previous authorization warrants attention regarding the full execution of this new, larger program. Institutional investor sentiment in Q1 2025 was varied, with 341 institutions increasing their holdings and 378 decreasing them. Notably, Capital World Investors augmented its position by 6,322,976 shares (+10.7%) and Pershing Square Capital Management added 6,111,593 shares (+17.5%). Conversely, The Manufacturers Life Insurance Company reduced its stake by 5,711,029 shares (-48.1%), Select Equity Group, L.P. divested 4,256,901 shares (-52.6%), and Charles Schwab Investment Management liquidated its entire holding of 3,788,312 shares. On the analyst front, Morgan Stanley issued an "Overweight" rating on May 19, 2025, and no sell ratings have been reported in recent months, indicating a generally favorable outlook from Wall Street.

Key Decisions for Investors

• Investors should interpret the renewed share repurchase program as a strong signal of management's belief in Brookfield's undervaluation, which could provide support for the share price, though the actual execution volume relative to the authorization will be a key factor to monitor given the prior bid's completion rate.
• The mixed institutional ownership changes during Q1 2025, characterized by both substantial new investments from prominent funds and significant divestitures, suggest a period of re-evaluation; therefore, closely tracking the progress and market impact of the new buyback program is advisable.
• Considering management's explicit stance on undervaluation and the supportive 'Overweight' rating from Morgan Stanley, current share price levels might be viewed as an attractive entry point for long-term investors, while remaining mindful of the inherent risks associated with forward-looking statements and the company's historical pattern of buyback utilization.